Evidence map›Paper›PMID 15212590›Full record

ArticlePharmacogenomics2004

The genomic response of skeletal muscle to methylprednisolone using microarrays: tailoring data mining to the structure of the pharmacogenomic time series.

Richard R Almon, Debra C DuBois, William H Piel, William J Jusko

Abstract read
In one paragraph

Article in Pharmacogenomics, 2004. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Temporal changes in gene expression in rainbow trout exposed to ethynyl estradiol.Comparative biochemistry and physiology. Toxicology & pharmacology : CBP · 2007
    Article
  16. Article
  17. Article
  18. Corticosteroid-regulated genes in rat kidney: mining time series array data.American journal of physiology. Endocrinology and metabolism · 2005
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Richard R AlmonDepartment of Biological Sciences, SUNY at Buffalo, Buffalo, NY 14260, USA. almon@eng.buffalo.edu
Debra C DuBois
William H Piel
William J Jusko

Funding

Corticosteroid Pharmacokinetics and PharmacodynamicsR37GM024211 · NIGMS · STATE UNIVERSITY OF NEW YORK AT BUFFALO · PI JUSKO, WILLIAM J. · 2005 to 2014
$6.4M
CORTICOSTEROID PHARMACOKINETICS/DYNAMICSR01GM024211 · NIGMS · STATE UNIVERSITY OF NEW YORK AT BUFFALO · PI JUSKO, WILLIAM J. · 1985 to 2018
$4.7M
A FUNCTIONAL GENOMICS HEART &LUNG DEVELOP. PROGRAMU01HL066614 · NHLBI · CHILDREN'S RESEARCH INSTITUTE · PI HOFFMAN, ERIC P · 2000 to 2003
$3.5M
Computational Approaches to Disease Causes and TreatmentP20GM067650 · NIGMS · STATE UNIVERSITY OF NEW YORK AT BUFFALO · PI ZHANG, AIDONG · 2003 to 2005
$1.2M
NHLBI NIH HHS U01 HL066614NHLBI NIH HHS U01 HL66614NIGMS NIH HHS 1 P20 GM67650NIGMS NIH HHS GM 24211NIGMS NIH HHS P20 GM067650NIGMS NIH HHS R01 GM024211NIGMS NIH HHS R37 GM024211
6 · The paper itself

Abstract

High-throughput data collection using gene microarrays has great potential as a method for addressing the pharmacogenomics of complex biological systems. Similarly, mechanism-based pharmacokinetic/pharmacodynamic modeling provides a tool for formulating quantitative testable hypotheses concerning the responses of complex biological systems. As the response of such systems to drugs generally entails cascades of molecular events in time, a time series design provides the best approach to capturing the full scope of drug effects. A major problem in using microarrays for high-throughput data collection is sorting through the massive amount of data in order to identify probe sets and genes of interest. Due to its inherent redundancy, a rich time series containing many time points and multiple samples per time point allows for the use of less stringent criteria of expression, expression change and data quality for initial filtering of unwanted probe sets. The remaining probe sets can then become the focus of more intense scrutiny by other methods, including temporal clustering, functional clustering and pharmacokinetic/pharmacodynamic modeling, which provide additional ways of identifying the probes and genes of pharmacological interest.

Indexed as

AdrenalectomyAnimalsMaleMethylprednisoloneMuscle, SkeletalOligonucleotide Array Sequence AnalysisPharmacogeneticsRatsRats, WistarRNA, ComplementaryTime FactorsMethylprednisoloneRNA, Complementary

Identifiers

PMID15212590
PMCPMC2607486

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.